vs

Side-by-side financial comparison of COHEN & STEERS, INC. (CNS) and Riley Exploration Permian, Inc. (REPX). Click either name above to swap in a different company.

COHEN & STEERS, INC. is the larger business by last-quarter revenue ($143.8M vs $97.3M, roughly 1.5× Riley Exploration Permian, Inc.). On growth, COHEN & STEERS, INC. posted the faster year-over-year revenue change (2.9% vs -5.3%). Over the past eight quarters, COHEN & STEERS, INC.'s revenue compounded faster (8.3% CAGR vs -1.2%).

Cohen & Steers is an American investment management company. It focuses on investments in real estate securities via real estate investment trusts (REIT) and alternative income via preferred securities.

Riley Exploration Permian, Inc. is an independent energy company focused on exploration, development, and production of crude oil, natural gas, and natural gas liquids primarily in the US Permian Basin spanning Texas and New Mexico. It prioritizes cost-efficient onshore reserve development to supply reliable energy products to North American markets.

CNS vs REPX — Head-to-Head

Bigger by revenue
CNS
CNS
1.5× larger
CNS
$143.8M
$97.3M
REPX
Growing faster (revenue YoY)
CNS
CNS
+8.2% gap
CNS
2.9%
-5.3%
REPX
Faster 2-yr revenue CAGR
CNS
CNS
Annualised
CNS
8.3%
-1.2%
REPX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CNS
CNS
REPX
REPX
Revenue
$143.8M
$97.3M
Net Profit
$34.9M
Gross Margin
Operating Margin
28.0%
26.9%
Net Margin
24.3%
Revenue YoY
2.9%
-5.3%
Net Profit YoY
-23.9%
EPS (diluted)
$0.67
$4.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CNS
CNS
REPX
REPX
Q4 25
$143.8M
$97.3M
Q3 25
$141.7M
$106.9M
Q2 25
$136.1M
$85.4M
Q1 25
$134.5M
$102.5M
Q4 24
$139.8M
$102.7M
Q3 24
$133.2M
$102.3M
Q2 24
$121.7M
$105.4M
Q1 24
$122.7M
$99.7M
Net Profit
CNS
CNS
REPX
REPX
Q4 25
$34.9M
Q3 25
$41.7M
$16.3M
Q2 25
$36.8M
$30.5M
Q1 25
$39.8M
$28.6M
Q4 24
$45.8M
Q3 24
$39.7M
$25.7M
Q2 24
$31.8M
$33.5M
Q1 24
$34.0M
$18.8M
Operating Margin
CNS
CNS
REPX
REPX
Q4 25
28.0%
26.9%
Q3 25
34.5%
27.0%
Q2 25
31.8%
33.7%
Q1 25
33.6%
48.3%
Q4 24
35.3%
31.2%
Q3 24
33.7%
17.1%
Q2 24
31.5%
50.9%
Q1 24
32.8%
50.7%
Net Margin
CNS
CNS
REPX
REPX
Q4 25
24.3%
Q3 25
29.4%
15.3%
Q2 25
27.1%
35.7%
Q1 25
29.6%
27.9%
Q4 24
32.8%
Q3 24
29.8%
25.1%
Q2 24
26.1%
31.8%
Q1 24
27.7%
18.8%
EPS (diluted)
CNS
CNS
REPX
REPX
Q4 25
$0.67
$4.02
Q3 25
$0.81
$0.77
Q2 25
$0.72
$1.44
Q1 25
$0.77
$1.36
Q4 24
$0.89
$0.52
Q3 24
$0.77
$1.21
Q2 24
$0.63
$1.59
Q1 24
$0.68
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CNS
CNS
REPX
REPX
Cash + ST InvestmentsLiquidity on hand
$145.5M
Total DebtLower is stronger
$247.9M
Stockholders' EquityBook value
$562.0M
$634.2M
Total Assets
$876.7M
$1.2B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CNS
CNS
REPX
REPX
Q4 25
$145.5M
Q3 25
$98.1M
Q2 25
$95.4M
Q1 25
$65.2M
Q4 24
$183.0M
Q3 24
$106.5M
Q2 24
$122.0M
Q1 24
$99.5M
Total Debt
CNS
CNS
REPX
REPX
Q4 25
$247.9M
Q3 25
$367.0M
Q2 25
$275.2M
Q1 25
$249.3M
Q4 24
$269.5M
Q3 24
$288.6M
Q2 24
$322.7M
Q1 24
$341.8M
Stockholders' Equity
CNS
CNS
REPX
REPX
Q4 25
$562.0M
$634.2M
Q3 25
$550.3M
$566.5M
Q2 25
$528.5M
$556.9M
Q1 25
$507.7M
$532.4M
Q4 24
$511.7M
$510.6M
Q3 24
$491.0M
$507.4M
Q2 24
$463.2M
$489.0M
Q1 24
$378.9M
$434.6M
Total Assets
CNS
CNS
REPX
REPX
Q4 25
$876.7M
$1.2B
Q3 25
$801.6M
$1.2B
Q2 25
$751.0M
$1.0B
Q1 25
$834.9M
$994.9M
Q4 24
$812.4M
$993.5M
Q3 24
$727.8M
$997.9M
Q2 24
$784.1M
$1.0B
Q1 24
$680.7M
$956.4M
Debt / Equity
CNS
CNS
REPX
REPX
Q4 25
0.39×
Q3 25
0.65×
Q2 25
0.49×
Q1 25
0.47×
Q4 24
0.53×
Q3 24
0.57×
Q2 24
0.66×
Q1 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CNS
CNS
REPX
REPX
Operating Cash FlowLast quarter
$-120.4M
$64.9M
Free Cash FlowOCF − Capex
$-126.4M
FCF MarginFCF / Revenue
-87.9%
Capex IntensityCapex / Revenue
4.2%
Cash ConversionOCF / Net Profit
-3.45×
TTM Free Cash FlowTrailing 4 quarters
$-253.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CNS
CNS
REPX
REPX
Q4 25
$-120.4M
$64.9M
Q3 25
$55.1M
$63.6M
Q2 25
$-67.6M
$33.6M
Q1 25
$-108.9M
$50.4M
Q4 24
$96.7M
$66.4M
Q3 24
$25.6M
$72.1M
Q2 24
$31.4M
$51.6M
Q1 24
$4.9M
$56.1M
Free Cash Flow
CNS
CNS
REPX
REPX
Q4 25
$-126.4M
Q3 25
$52.6M
Q2 25
$-69.8M
Q1 25
$-110.0M
Q4 24
$85.0M
Q3 24
$24.2M
Q2 24
$27.1M
Q1 24
$537.0K
FCF Margin
CNS
CNS
REPX
REPX
Q4 25
-87.9%
Q3 25
37.1%
Q2 25
-51.3%
Q1 25
-81.8%
Q4 24
60.8%
Q3 24
18.2%
Q2 24
22.3%
Q1 24
0.4%
Capex Intensity
CNS
CNS
REPX
REPX
Q4 25
4.2%
Q3 25
1.8%
Q2 25
1.6%
Q1 25
0.8%
Q4 24
8.3%
Q3 24
1.1%
Q2 24
3.5%
Q1 24
3.5%
Cash Conversion
CNS
CNS
REPX
REPX
Q4 25
-3.45×
Q3 25
1.32×
3.90×
Q2 25
-1.84×
1.10×
Q1 25
-2.74×
1.76×
Q4 24
2.11×
Q3 24
0.65×
2.81×
Q2 24
0.99×
1.54×
Q1 24
0.14×
2.99×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons